First-line pembrolizumab + chemotherapy in Japanese patients with advanced/metastatic esophageal cancer from KEYNOTE-590.
Takashi KojimaHiroki HaraAkihito TsujiHisateru YasuiKei MuroTaroh SatohTakashi OgataRyu IshiharaMasahiro GotoHideo BabaTomohiro NishinaShirong HanTomoko SakataNaoyoshi YatsuzukaToshihiko DoiKen KatoPublished in: Esophagus : official journal of the Japan Esophageal Society (2022)
ClinicalTrials.gov, NCT03189719.